Home
/
BIOVIE INC.
/
Financials
/
Quarterly
BIOVIE INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BIOVIE INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2016
Sep 30, 2016
$0
Jan 19, 2017
Q1
2016
Sep 30, 2015
$0
Jan 19, 2017
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
($6.07M)
Feb 6, 2026
Q2
2026
Sep 30, 2025
($5.09M)
Feb 6, 2026
Q1
2026
Sep 30, 2025
($5.09M)
Nov 10, 2025
Q3
2025
Mar 31, 2025
($2.79M)
May 12, 2025
Q2
2026
Dec 31, 2024
($7.11M)
Feb 6, 2026
Q3
2025
Dec 31, 2024
($7.11M)
May 12, 2025
Q2
2026
Sep 30, 2024
($4.15M)
Feb 6, 2026
Q3
2025
Sep 30, 2024
($4.15M)
May 12, 2025
Q1
2026
Sep 30, 2024
($4.15M)
Nov 10, 2025
Q3
2025
Mar 31, 2024
($8.07M)
May 12, 2025
Q3
2025
Dec 31, 2023
($8.40M)
May 12, 2025
Q2
2025
Dec 31, 2023
($8.40M)
Feb 11, 2025
Q3
2025
Sep 30, 2023
($10.71M)
May 12, 2025
Q1
2024
Sep 30, 2023
($10.71M)
Nov 13, 2024
Q2
2025
Sep 30, 2023
($10.71M)
Feb 11, 2025
Q3
2023
Mar 31, 2023
($15.04M)
May 14, 2024
Q3
2023
Dec 31, 2022
($15.69M)
May 14, 2024
Q2
2023
Dec 31, 2022
($15.69M)
Feb 13, 2024
Q3
2023
Sep 30, 2022
($10.42M)
May 14, 2024
Q1
2023
Sep 30, 2022
($10.42M)
Nov 8, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
($6.26M)
Feb 6, 2026
Q1
2026
Sep 30, 2025
($5.28M)
Nov 10, 2025
Q3
2025
Mar 31, 2025
($2.99M)
May 12, 2025
Q2
2026
Dec 31, 2024
($7.29M)
Feb 6, 2026
Q1
2026
Sep 30, 2024
($4.12M)
Nov 10, 2025
Q3
2025
Mar 31, 2024
($7.73M)
May 12, 2025
Q2
2025
Dec 31, 2023
($8.78M)
Feb 11, 2025
Q1
2024
Sep 30, 2023
($10.88M)
Nov 13, 2024
Q3
2023
Mar 31, 2023
($13.77M)
May 14, 2024
Q2
2023
Dec 31, 2022
($11.49M)
Feb 13, 2024
Q1
2023
Sep 30, 2022
($8.83M)
Nov 8, 2023
Q3
2023
Mar 31, 2022
($5.75M)
May 12, 2023
Q2
2022
Dec 31, 2021
($6.67M)
Feb 10, 2023
Q1
2022
Sep 30, 2021
($5.55M)
Nov 4, 2022
Q3
2022
Mar 31, 2021
($3.00M)
May 11, 2022
Q2
2022
Dec 31, 2020
($3.06M)
Feb 8, 2022
Q1
2022
Sep 30, 2020
($386.8K)
Nov 10, 2021
Q3
2021
Mar 31, 2020
($699.3K)
May 10, 2021
Q2
2021
Dec 31, 2019
($710.4K)
Jan 29, 2021
Q1
2021
Sep 30, 2019
($706.2K)
Nov 5, 2020